Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11680268 Methods for improving CRISPR/Cas-mediated genome-editing

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Editas Medicine
Editas Medicine
0
Date Filed
November 9, 2015
0
Date of Patent
June 20, 2023
0
Patent Applicant
Editas Medicine
Editas Medicine
0
Patent Application Number
15524672
0
Patent Citations
‌
US Patent 8889418 Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation
0
‌
US Patent 8895308 Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation
0
‌
US Patent 8945839 CRISPR-Cas systems and methods for altering expression of gene products
0
‌
US Patent 8993233 Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains
0
‌
US Patent 8999641 Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains
0
‌
US Patent 9023649 RNA-guided human genome engineering
0
‌
US Patent 9234213 Compositions and methods directed to CRISPR/Cas genomic engineering systems
0
‌
US Patent 9260723 RNA-guided human genome engineering
0
‌
US Patent 9267135 RNA-guided transcriptional regulation
0
‌
US Patent 9322037 Cas9-FokI fusion proteins and uses thereof
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11680268
0
Patent Primary Examiner
‌
Nancy J Leith
0

Find more entities like US Patent 11680268 Methods for improving CRISPR/Cas-mediated genome-editing

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.